NKGen Biotech

Santa Ana, United States

NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

$2.0M raised

Jul 2025

Post-IPO Equity

Biotechnology Life Science

Top Investors

Gaingels HekaBio Paul Y. Song

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NKGen Biotech

How much funding has NKGen Biotech raised?

NKGen Biotech has raised $2.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.

Who are NKGen Biotech's investors?

NKGen Biotech's investors include Gaingels, HekaBio, Paul Y. Song.

Where is NKGen Biotech headquartered?

NKGen Biotech is headquartered in Santa Ana, United States.

What does NKGen Biotech do?

NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

What stage is NKGen Biotech at?

NKGen Biotech is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 14, 2025.

MLA

"NKGen Biotech — Funding & Investors." VCBacked, July 14, 2025, https://www.vcbacked.co/company/nkgen-biotech. Accessed July 2, 2026.

APA

VCBacked. (2025). NKGen Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nkgen-biotech

Wikipedia (cite web)

{{cite web |title=NKGen Biotech — Funding & Investors |url=https://www.vcbacked.co/company/nkgen-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 14, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K